Animation - Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
Slide Show - Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
1.
What is immunotherapy and how does it work for lung cancer?
2.
What types of immunotherapy are used to treat lung cancer?
3.
What side effects can be associated with immunotherapy for lung cancer?
4.
What is comprehensive biomarker testing for lung cancer? What do I need to know?
Expert Video - What is immunotherapy and how does it work for lung cancer?
Medical oncologists and lung cancer experts Dr. Joseph Leach and Dr. Naomi Fujioka provide an overview of immunotherapy and how it works for treating lung cancer. They also talk about immune checkpoints PD-L1 and CTLA-4. Currently, doctors test for the presence of PD-L1 in all lung cancers and this information is very important for treatment decisions.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Section: Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
Expert Videos
Animation - Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
Slide Show - Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
1.
What is immunotherapy and how does it work for lung cancer?
2.
What types of immunotherapy are used to treat lung cancer?
3.
What side effects can be associated with immunotherapy for lung cancer?
4.
What is comprehensive biomarker testing for lung cancer? What do I need to know?
